Mark Sorbero
Overview
Explore the profile of Mark Sorbero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
670
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stein B, Sheng F, Taylor E, Davis C, Griffin B, Sorbero M, et al.
Drug Alcohol Depend
. 2025 Jan;
267():112533.
PMID: 39823664
Importance: States have implemented multiple policies likely to influence opioid prescribing; few national general population studies examine those policies' effects on per-capita opioid morphine milligram equivalents (MME) dispensed. Objective: To...
2.
Stein B, Saloner B, Sheng F, Sorbero M, Dick A, Gordon A
J Gen Intern Med
. 2024 Nov;
PMID: 39543071
Importance: State policies facilitating telehealth implemented early in COVID may support buprenorphine treatment of opioid use disorder. However, little empirical information is available about those policies' effects. Objective: Examine association...
3.
Priest K, Merlin J, Lai J, Sorbero M, Taylor E, Dick A, et al.
J Gen Intern Med
. 2024 Jul;
39(15):2942-2951.
PMID: 39020230
Background: States have implemented policies to decrease clinically unnecessary opioid prescribing, but few studies have examined how state policies affect opioid dispensing rate trends for surgical patients. Objective: To examine...
4.
Golan O, Sheng F, Dick A, Sorbero M, Whitaker D, Andraka-Christou B, et al.
Drug Alcohol Depend Rep
. 2023 Oct;
9:100193.
PMID: 37876376
Background: Although use of buprenorphine for treating opioid use disorder increased over the past decade, buprenorphine utilization remains limited in lower-income and rural areas. We examine how the Affordable Care...
5.
Stein B, Landis R, Sheng F, Saloner B, Gordon A, Sorbero M, et al.
J Gen Intern Med
. 2022 Dec;
38(3):733-737.
PMID: 36474004
Background: During the COVID pandemic, overall buprenorphine treatment appeared to remain relatively stable, despite some studies suggesting a decrease in patients starting buprenorphine. There is a paucity of empirical information...
6.
Landis R, Opper I, Saloner B, Gordon A, Leslie D, Sorbero M, et al.
Drug Alcohol Depend
. 2022 Nov;
241:109669.
PMID: 36332589
Background: Buprenorphine is an effective medication for the treatment of opioid use disorder (OUD), but the association between prior authorization policies and quality of care for individuals receiving buprenorphine treatment...
7.
Levin J, Landis R, Sorbero M, Dick A, Saloner B, Stein B
Drug Alcohol Depend
. 2022 Jun;
237:109510.
PMID: 35753279
Background: The number and types of clinicians prescribing buprenorphine treatment for opioid use disorder (OUD) have increased over the past two decades, but there is little information on how potential...
8.
Landis R, Levin J, Saloner B, Gordon A, Dick A, Sherry T, et al.
Subst Abus
. 2022 Apr;
43(1):1057-1071.
PMID: 35442178
Buprenorphine is a key medication to treat opioid use disorder, but little is known about how treatment quality varies across sociodemographic groups. Objective: We examined measures of treatment quality and...
9.
Harrison J, Kerber R, Andraka-Christou B, Sorbero M, Stein B
Med Care Res Rev
. 2022 Apr;
79(6):789-797.
PMID: 35435071
Nurse practitioner (NP) and physician assistant (PA) prescribing can increase access to buprenorphine treatment for opioid use disorder. In this cross-sectional study, we used deidentified claims from approximately 90% of...
10.
Stein B, Saloner B, Kerber R, Sorbero M, Gordon A
Ann Emerg Med
. 2022 Mar;
79(5):441-450.
PMID: 35305851
Study Objective: Buprenorphine treatment for opioid use disorder provided in the emergency department with subsequent buprenorphine treatment by community prescribers is associated with improved outcomes, but the frequency with which...